EGM
KZIA

Engineers Gate Manager’s Kazia Therapeutics KZIA Stock Holding History

Engineers Gate Manager’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
+14,975
New +$182K ﹤0.01% 1943
2026
Q1 		– Sell
-10,388
Closed -$71.6K – 2389
2025
Q4 		$71.6K Buy
+10,388
New +$88.5K ﹤0.01% 1954

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Engineers Gate Manager's KZIA Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 14,975 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #1943 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in KZIA as recently as Q4 2025.

Engineers Gate Manager first reported a position in KZIA in Q4 2025 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Engineers Gate Manager held 14,975 shares of Kazia Therapeutics worth $211K as of Q2 2026.
  • Kazia Therapeutics was a new Engineers Gate Manager position in Q2 2026.
  • Kazia Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1943 holding.
  • Engineers Gate Manager first reported a position in Kazia Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.